Bml Capital Management, LLC Portfolio Holdings

Bml Capital Management, LLC

  • $170 Billion
  • Q3 2024

Bml Capital Management, LLC has filed its 13F form on November 05, 2024 for Q3 2024 where it was disclosed a total value porftolio of $170 Billion distributed in 29 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ishares Trishares 0 3 Mnth Tre with a value of $27.2B, Instil Bio Inc with a value of $22.6B, Atea Pharmaceuticals, Inc. with a value of $22.3B, Aclaris Therapeutics, Inc. with a value of $16.4B, and Spdr Bloomberg 1 3 Month T Bil with a value of $16.1B.

Examining the 13F form we can see an increase of $29.8B in the current position value, from $140B to 170B.

Bml Capital Management, LLC is based out at Zionsville, IN

Below you can find more details about Bml Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $170 Billion
Healthcare: $75.1 Billion
ETFs: $43.3 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$0
$27.2 Billion 16.0% of portfolio
270,000
Q3 2023 Added 50.0%
Instil Bio Inc
-
$22.6 Billion 13.27% of portfolio
-
Q3 2024 Reduced 14.34%
$281M
$22.3 Billion 13.11% of portfolio
6,650,000
Q3 2024 Added 4.3%
$253M
$16.4 Billion 9.64% of portfolio
14,250,000
Q3 2024 Added 9.72%
$0
$16.1 Billion 9.45% of portfolio
175,000
Q3 2024 Reduced 12.5%
Adverum Biotechnologies Inc
-
$15.9 Billion 9.37% of portfolio
-
Q3 2024 Added 15.36%
Tectonic Therapeutic Inc
-
$6.42 Billion 3.78% of portfolio
-
Q3 2024 Reduced 54.56%
$26M
$6.15 Billion 3.62% of portfolio
5,749,432
Q3 2024 New
$41.1M
$5.88 Billion 3.46% of portfolio
3,457,395
Q3 2024 Added 29.38%
$90.9M
$5.33 Billion 3.14% of portfolio
2,186,191
Q3 2024 Added 62.06%
$43.2M
$4.18 Billion 2.46% of portfolio
4,100,002
Q3 2024 Added 555.82%
$48.3M
$4.12 Billion 2.42% of portfolio
2,000,000
Q3 2024 New
$55M
$3.01 Billion 1.77% of portfolio
2,093,232
Q3 2024 Added 2.45%
$73.5M
$2.52 Billion 1.48% of portfolio
1,688,772
Q3 2024 Added 28.97%
Astrotech Corp
-
$1.76 Billion 1.04% of portfolio
-
Q4 2022 New
$55.2M
$1.73 Billion 1.02% of portfolio
1,136,091
Q3 2024 Added 3.01%
$62M
$1.25 Billion 0.74% of portfolio
723,288
Q3 2024 Added 23.61%
$288M
$1.07 Billion 0.63% of portfolio
228,500
Q3 2024 Reduced 42.63%
-
$854 Million 0.5% of portfolio
-
Q1 2024 Added 5.5%
Pieris Pharmaceuticals Inc
-
$699 Million 0.41% of portfolio
-
Q3 2024 New
Calcimedica Inc
-
$682 Million 0.4% of portfolio
-
Q3 2024 Reduced 4.07%
$51.2M
$488 Million 0.29% of portfolio
603,086
Q2 2024 Added 200.85%
Talis Biomedical Corp
-
$460 Million 0.27% of portfolio
-
Q3 2024 Added 481.85%
Vistagen Therapeutics Inc
-
$452 Million 0.27% of portfolio
-
Q4 2023 Added 50.0%
Forte Biosciences Inc
-
$394 Million 0.23% of portfolio
-
Q3 2024 New
$33M
$379 Million 0.22% of portfolio
276,465
Q2 2024 Reduced 9.79%
$327M
$261 Million 0.15% of portfolio
180,000
Q4 2023 Added 20.0%
$62.2M
$34.8 Million 0.02% of portfolio
19,760
Q3 2024 New

Summary

  • Portfolio
  • No. of Stocks 29
  • Current Value $170 Billion
  • Prior Value $140 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 05, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 5 stocks
  • Additional Purchases 11 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 6 stocks
Track This Portfolio

Track Bml Capital Management, LLC Portfolio

Follow Bml Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bml Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bml Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email